HU191853B - Process for prducing 1,4-dihydro-pyridine derviatives and pharmaceutical compositions containing them - Google Patents

Process for prducing 1,4-dihydro-pyridine derviatives and pharmaceutical compositions containing them Download PDF

Info

Publication number
HU191853B
HU191853B HU832113A HU211383A HU191853B HU 191853 B HU191853 B HU 191853B HU 832113 A HU832113 A HU 832113A HU 211383 A HU211383 A HU 211383A HU 191853 B HU191853 B HU 191853B
Authority
HU
Hungary
Prior art keywords
formula
compound
group
compounds
preparation
Prior art date
Application number
HU832113A
Other languages
English (en)
Hungarian (hu)
Inventor
Arnold Vogel
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of HU191853B publication Critical patent/HU191853B/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/12—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
HU832113A 1982-06-15 1983-06-14 Process for prducing 1,4-dihydro-pyridine derviatives and pharmaceutical compositions containing them HU191853B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH369382 1982-06-15
CH369282 1982-06-15

Publications (1)

Publication Number Publication Date
HU191853B true HU191853B (en) 1987-04-28

Family

ID=25693638

Family Applications (1)

Application Number Title Priority Date Filing Date
HU832113A HU191853B (en) 1982-06-15 1983-06-14 Process for prducing 1,4-dihydro-pyridine derviatives and pharmaceutical compositions containing them

Country Status (19)

Country Link
AU (1) AU1575383A (fr)
BE (1) BE897000A (fr)
CA (1) CA1208639A (fr)
CH (1) CH660593A5 (fr)
DE (1) DE3320616A1 (fr)
DK (1) DK271183A (fr)
ES (2) ES8504179A1 (fr)
FI (1) FI832072L (fr)
FR (1) FR2528431B1 (fr)
GB (1) GB2122192B (fr)
HU (1) HU191853B (fr)
IT (1) IT1178353B (fr)
NL (1) NL8302067A (fr)
NZ (1) NZ204536A (fr)
PH (1) PH23436A (fr)
PT (1) PT76870B (fr)
SE (1) SE8303385L (fr)
WO (1) WO1984000033A1 (fr)
ZA (1) ZA834409B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3431152A1 (de) * 1984-08-24 1986-03-06 Cassella Ag, 6000 Frankfurt Verfahren zur herstellung optisch aktiver, substituierter 1,4-dihydropyridine und ihre verwendung als arzneimittel
GB8428552D0 (en) * 1984-11-12 1984-12-19 Sandoz Ltd Organic compounds
US5260321A (en) * 1984-11-12 1993-11-09 Sandoz Ltd. Use of 1,4-dihydropyridine derivatives and combinations thereof with calcitonins
DE3447169A1 (de) * 1984-12-22 1986-07-03 Bayer Ag, 5090 Leverkusen Optisch aktive nitrodihydropyridine, verfahren zur herstellung und ihre verwendung in arzneimitteln
US4920225A (en) * 1986-12-22 1990-04-24 Laboratoires Syntex S.A. Resolution of 1,4-dihydropyridine derivatives
EP0287828A1 (fr) * 1987-03-27 1988-10-26 Byk Gulden Lomberg Chemische Fabrik GmbH Produits intermédiaires et leur préparation
DE4041814A1 (de) * 1990-12-24 1992-07-02 Byk Gulden Lomberg Chem Fab Verfahren zur herstellung von dihydrophyridincarbonsaeuren
US5135936A (en) * 1991-03-05 1992-08-04 Marion Merrell Dow Inc. Isomers of 1-azabicyclo[2.2.2]oct-3-yl methyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinediacarboxylic and their use as calcium antagonists
CN100425599C (zh) * 2005-12-31 2008-10-15 清华大学 一种有机电致发光材料及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI64938C (fi) * 1977-06-20 1984-02-10 Sandoz Ag Foerfarande foer framstaellning av nya terapeutiskt anvaendbara bensoxa- och bensotiadiazolyl-1,4-dihydropyridinderivat
CH639659A5 (de) * 1978-12-18 1983-11-30 Sandoz Ag Neue 1,4-dihydropyridinderivate, deren herstellung und verwendung.
DE2949464A1 (de) * 1978-12-18 1980-06-26 Sandoz Ag Benzoxadiazole und benzothiadiazole, ihre herstellung und verwendung
FI813460L (fi) * 1980-11-10 1982-05-11 Sandoz Ag Nya 4-(2,1,3-benzoxadiazol-4-yl)-1,4-dihydro-pyridinderivat deras framstaellningsfoerfarande och dessa innehaollande farmaceutiska kompositioner

Also Published As

Publication number Publication date
FI832072L (fi) 1983-12-16
DE3320616A1 (de) 1983-12-15
DK271183D0 (da) 1983-06-13
SE8303385L (sv) 1983-12-16
FR2528431A1 (fr) 1983-12-16
GB2122192A (en) 1984-01-11
CH660593A5 (de) 1987-05-15
NZ204536A (en) 1986-09-10
AU1575383A (en) 1983-12-22
ES8604578A1 (es) 1986-02-01
CA1208639A (fr) 1986-07-29
BE897000A (fr) 1983-12-09
PT76870B (en) 1986-02-27
ZA834409B (en) 1985-02-27
GB8316054D0 (en) 1983-07-20
IT1178353B (it) 1987-09-09
FI832072A0 (fi) 1983-06-08
ES523243A0 (es) 1985-04-01
NL8302067A (nl) 1984-01-02
DK271183A (da) 1983-12-16
WO1984000033A1 (fr) 1984-01-05
ES538157A0 (es) 1986-02-01
SE8303385D0 (sv) 1983-06-14
IT8348488A0 (it) 1983-06-13
ES8504179A1 (es) 1985-04-01
GB2122192B (en) 1985-12-18
PH23436A (en) 1989-08-07
PT76870A (en) 1983-07-01
FR2528431B1 (fr) 1986-01-10

Similar Documents

Publication Publication Date Title
BE1014452A6 (nl) Werkwijze voor het maken van amlodipinemaleaat.
CS418891A3 (en) Dihydropyridine derivatives, process of their preparation andpharmaceuticals containing said derivatives
HU184821B (en) Process for preparing new optically active derivatives of 1,4-dihydro-pyridine
OA12648A (en) Novel crystalline polymorphic forms of lercanidipine hydrochloride and process for their preparation.
HU191853B (en) Process for prducing 1,4-dihydro-pyridine derviatives and pharmaceutical compositions containing them
CA1330994C (fr) Derives flavone
NZ197582A (en) Dextrorotatory trans-4a,9b-5phenyl-2,3,4,4a,5,9b-hexahydro-1h-pyrido(4,3-b) indoles
JPH03170465A (ja) ピリダジン誘導体、その製造方法及び該誘導体を含有する医薬組成物
WO2009092284A1 (fr) Dérivés de benzocycloheptène, procédés de préparation et utilisations pharmaceutiques de ces derniers
CS214796B2 (en) Method of making the new derivatives of 4-amino-2-piperidinochinazoline
JPH07113016B2 (ja) １，４−ジヒドロピリジン誘導体、その製造方法及びその誘導体を含有する高血圧治療用組成物
FR2549058A1 (fr) Nouveaux derives de la 1,4-dihydropyridine, leur preparation et leur utilisation comme medicaments
JPH04230685A (ja) インドロナフチリジン類
JP2007084567A (ja) フエニル−置換１，４−ジヒドロピリジン類
US2903460A (en) Pyrazolone derivatives
JPH0319236B2 (fr)
US4886819A (en) Dihydropyridine derivatives and pharmaceutical composition thereof
US4267331A (en) Process for the production of 2-substituted pyrido[4,3-b]-indoles
US3084161A (en) New 3-methylsulphinyl phenothiazine derivatives
US4707482A (en) 4-(2,1,3-benzoxadiazol and benzothiadiazol-4-4L)-1,4-dihydropyridine-3,5-dicarboxylic acid esters useful as antihypertensives
US5741907A (en) Pharmacologically active enantiomers
JP2007512260A (ja) ｛Ｎ−［１−（Ｓ）−カルボアルコキシ−３−フェニルプロピル］−Ｓ−アラニル−２Ｓ，３ａＲ，７ａＳ−オクタヒドロインドール−２−カルボン酸｝化合物類の製造方法
HU188342B (en) Process for preparing new dihydropyridine derivatives
HU184233B (en) Process for preparing 4-amino-substituted-2-piperidino-quinazoline derivatives
HU187140B (en) Process for preparing new aburnan-oxima ethers